Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126132311 | 12613231 | 1 | I | 20160407 | 20160720 | 20160802 | 20160802 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-060736 | BRISTOL MYERS SQUIBB | 71.67 | YR | F | Y | 0.00000 | 20160802 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126132311 | 12613231 | 1 | PS | COUMADINE | WARFARIN SODIUM | 1 | Oral | 0.75 DF, QD | U | 9218 | .75 | DF | TABLET | QD | |||||
| 126132311 | 12613231 | 2 | I | TAMIFLU | OSELTAMIVIR PHOSPHATE | 1 | Oral | 75 MG, QD | U | 0 | 75 | MG | CAPSULE | QD | |||||
| 126132311 | 12613231 | 3 | I | AUGMENTIN | AMOXICILLINCLAVULANATE POTASSIUM | 1 | Intravenous (not otherwise specified) | 1 DF, UNK | U | 0 | 1 | DF | |||||||
| 126132311 | 12613231 | 4 | I | CEFTRIAXONE. | CEFTRIAXONE | 1 | Intravenous (not otherwise specified) | 1 GBQ, UNK | U | 0 | 1 | GBQ | |||||||
| 126132311 | 12613231 | 5 | I | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Intravenous (not otherwise specified) | 1.6 G, BID | U | 0 | 1.6 | G | BID | ||||||
| 126132311 | 12613231 | 6 | I | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Intravenous (not otherwise specified) | 1 G, UNK | U | 0 | 1 | G | |||||||
| 126132311 | 12613231 | 7 | C | SPECIAFOLDINE | FOLIC ACID | 1 | Unknown | 5 MG, BID | U | 0 | 5 | MG | BID | ||||||
| 126132311 | 12613231 | 8 | C | ASPEGIC | ASPIRIN DL-LYSINE | 1 | Unknown | 100 MG, QD | U | 0 | 100 | MG | QD | ||||||
| 126132311 | 12613231 | 9 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | Unknown | U | 0 | ||||||||||
| 126132311 | 12613231 | 10 | C | APIDRA | INSULIN GLULISINE | 1 | Unknown | U | 0 | ||||||||||
| 126132311 | 12613231 | 11 | C | LANTUS | INSULIN GLARGINE | 1 | Unknown | U | 0 | ||||||||||
| 126132311 | 12613231 | 12 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 80 MG, UNK | U | 0 | 80 | MG | |||||||
| 126132311 | 12613231 | 13 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 40 MG, UNK | U | 0 | 40 | MG | |||||||
| 126132311 | 12613231 | 14 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | Unknown | 100 ?G, UNK | U | 0 | 100 | UG | |||||||
| 126132311 | 12613231 | 15 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | QD | ||||||
| 126132311 | 12613231 | 16 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126132311 | 12613231 | 1 | Atrial flutter |
| 126132311 | 12613231 | 2 | Lung infection |
| 126132311 | 12613231 | 3 | Lung infection |
| 126132311 | 12613231 | 4 | Lung infection |
| 126132311 | 12613231 | 5 | Lung infection |
| 126132311 | 12613231 | 6 | Lung infection |
| 126132311 | 12613231 | 7 | Product used for unknown indication |
| 126132311 | 12613231 | 8 | Product used for unknown indication |
| 126132311 | 12613231 | 9 | Product used for unknown indication |
| 126132311 | 12613231 | 10 | Product used for unknown indication |
| 126132311 | 12613231 | 11 | Product used for unknown indication |
| 126132311 | 12613231 | 12 | Product used for unknown indication |
| 126132311 | 12613231 | 14 | Product used for unknown indication |
| 126132311 | 12613231 | 15 | Product used for unknown indication |
| 126132311 | 12613231 | 16 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126132311 | 12613231 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126132311 | 12613231 | Drug interaction | |
| 126132311 | 12613231 | Haemorrhoidal haemorrhage | |
| 126132311 | 12613231 | International normalised ratio increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126132311 | 12613231 | 2 | 20160406 | 0 | ||
| 126132311 | 12613231 | 3 | 20160406 | 0 | ||
| 126132311 | 12613231 | 4 | 20160406 | 0 | ||
| 126132311 | 12613231 | 5 | 20160407 | 0 | ||
| 126132311 | 12613231 | 6 | 20160406 | 0 |